NZ 613786 The disclosure relates to pyrrolopyridine-sulfonamide derivatives of formula (I), wherein the variables are as defined in the specification. These compounds are suitable for treating diseases or conditions mediated by B-Raf protein kinase, wherein said disease or condition is particularly selected from melanomer, thyroid or colon cancer.